|
RNF149 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.663600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.998200E-02 |
| Normal-vs-Stage2 |
1.193700E-02 |
| Normal-vs-Stage3 |
5.582100E-02 |
| Normal-vs-Stage4 |
1.581840E-02 |
| Stage1-vs-Stage2 |
4.90600000002672E-06 |
| Stage1-vs-Stage3 |
7.648400E-01 |
| Stage1-vs-Stage4 |
3.202600E-01 |
| Stage2-vs-Stage3 |
3.90030000000374E-05 |
| Stage2-vs-Stage4 |
1.74598999999054E-05 |
| Stage3-vs-Stage4 |
5.467400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.523960E-02 |
| Normal-vs-AfricanAmerican |
2.834000E-01 |
| Normal-vs-Asian |
6.430200E-02 |
| Caucasian-vs-AfricanAmerican |
6.485800E-01 |
| Caucasian-vs-Asian |
9.475600E-01 |
| AfricanAmerican-vs-Asian |
6.646200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.829800E-01 |
| Normal-vs-Female |
8.065800E-02 |
| Male-vs-Female |
6.038600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.849700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.729580E-01 |
| Normal-vs-Age(61-80Yrs) |
9.360000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.054400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.204200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.852100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.001800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.530170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.219200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.975400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.242000E-01 |
| Classical-VS-Follicular |
1.62625468647093E-12 |
| Classical-VS-Other |
1.774970E-01 |
| Classical-VS-Normal |
6.993100E-04 |
| Tall-VS-Follicular |
1.48720036285965E-10 |
| Tall-VS-Other |
2.247800E-01 |
| Tall-VS-Normal |
5.603800E-04 |
| Follicular-VS-Other |
1.056560E-01 |
| Follicular-VS-Normal |
7.52950000000308E-05 |
| Other-VS-Normal |
9.812200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.611400E-01 |
| Normal-vs-N1 |
7.618500E-02 |
| N0-vs-N1 |
2.219900E-02 |
|
|
